Harmony Biosciences to present EPX-100 trial data at neurology meeting

April 16, 2026 8:05 AM

Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) announced it will present data from the open-label extension phase of its ongoing Phase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found